ESC Premium Access

Hypercholesterolemia management - What will be our options after tomorrow?

Event: ESC CONGRESS 2019
Topic: Risk Factors and Prevention
Session type: Satellite Symposium
Sponsored by Mylan
Date: 1 September 2019
Time: 13:00 - 14:00

Session

4 presentations in this session

To be or not to be…but at which goal?

Speaker: Professor L. Tokgozoglu (Ankara, TR)
Thumbnail

Combination therapy in CV risk reduction: what are we waiting for in dyslipidaemia management?

Speaker: Professor P. Steg (Paris, FR)
Thumbnail

LDL-C reducing agents; what genetic tells us

Speaker: Professor B. Ference (Cambridge, GB)
Thumbnail

Getting to goals cost effectively, how can we make a difference?

Speaker: Professor E. Stroes (Amsterdam, NL)
Thumbnail

4 speakers from this session

Professor Lale Tokgozoglu

Hacettepe University, Ankara (Turkey)
23 presentations
0 follower

Professor Philippe Gabriel Steg

Hospital Bichat-Claude Bernard, Paris (France)
44 presentations
2 followers

Professor Brian A Ference

University of Cambridge, Cambridge (United Kingdom of Great Britain & Northern Ireland)
24 presentations
1 follower

Professor Erik Stroes

Academic Medical Center of Amsterdam, Amsterdam (Netherlands (The))
17 presentations
0 follower

This platform is supported by

logo Novo Nordisk